de Guadalupe Chávez-López, María <br/><br/>
Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC.  [electronic resource] 

 -  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine  Aug 2015 
 - 6149-58 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0380 
<br/><br/><label>Standard No.: </label>10.1007/s13277-015-3299-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Astemizole--administration & dosage<br/>Biomarkers, Tumor--biosynthesis<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Proliferation--drug effects<br/>Diethylnitrosamine--administration & dosage<br/>Ether-A-Go-Go Potassium Channels--biosynthesis<br/>Gene Expression Regulation, Neoplastic<br/>Hep G2 Cells<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Neoplasm Staging<br/>Prognosis<br/>Rats<br/>gamma-Glutamyltransferase--biosynthesis